Skip to main content
Log in

Prevalence and Clinical Utility of Human Papilloma Virus Genotyping in Patients with Cervical Lesions

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

Cervical cancer is the commonest cancer among Indian women. High-risk human papilloma virus (HPV) detection holds the potential to be used as a tool to identify women, at risk of subsequent development of cervical cancer. There is a pressing need to identify prevalence of asymptomatic cervical HPV infection in local population. In our study, we explored the prevalence of HPV genotypes and their distribution in women with cervical lesions.

Methods

Scrape specimens were obtained from 100 women (study group) with cervical abnormalities. HPV was detected with amplicor HPV tests, and the individual genotypes in these specimens were identified by Hybribio Genoarray test kit. Fifty specimens were also collected from females with healthy cervix (control group). The present study also aimed to determine the status of HPV prevalence and its association with different sociodemographic factors.

Results

Out of the total number of 100 samples, 10 (10 %) women tested positive for HPV DNA. Among them, HPV 18 was observed in 6, HPV 16 in 2, HPV 52 and HPV 39 in one each. Fifty specimens collected from patients with healthy cervix were not infected with any of the HPV genotype.

Conclusions

Our study generates data of HPV prevalence in patients with cervical lesions visiting tertiary care institute. The data generated will be useful for laying guidelines for mass screening of HPV detection, treatment, and prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Burd EM. Human papilloma virus and cervical cancer. Clin Microbiol Rev. 2003; 16:1–17.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Braaten KP,Laufer MR. Human papilloma virus (HPV), HPV related disease, and the HPV vaccine. Rev Obstet Gynecol. 2008; 1(1):02–10.

    Google Scholar 

  3. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000; 98:49–52

    CAS  PubMed  Google Scholar 

  4. Speich N, Schmitt C, Bollmann R, et al. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol. 2004; 53:125–28

    Article  CAS  PubMed  Google Scholar 

  5. Ferlay J, Parkin DM, Pisani P. GLOBOLAN 2002: Cancer incidence, mortality, and prevalence worldwide version 1.0 IARC Cancer Base No. 5. Lyon: IARC press; 2005.

    Google Scholar 

  6. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366:991–8.

    Article  CAS  PubMed  Google Scholar 

  7. Forbes BA, Sahm DF, Weissfeld AS. Laboratory methods in basic virology. Bailey and Scott’s diagnostic microbiology. 12th ed. St. Louis: Mosby Elsevier; 2007. p. 729–30.

    Google Scholar 

  8. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med. 2003; 348: 518–27.

    Article  PubMed  Google Scholar 

  9. Jastreboff AM, Cymet T. Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J. 2002; 78:225–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Stanley M. Genital human papillomavirus infections and prospective therapies. J Natl Cancer Inst. 2003; 31:117–24.

    Article  Google Scholar 

  11. Rozendaal L, Walboomers JM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996; 68:766–9.

    Article  CAS  PubMed  Google Scholar 

  12. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology human papillomavirus testing and risk for cervical neoplasia: A 10 -year cohort analysis. J Natl Cancer Inst. 2003; 95:46–52.

    Article  PubMed  Google Scholar 

  13. Walker JL, Wang SS, Schiffman M, et al. ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during postcolposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol. 2006; 195:341–8.

    Article  PubMed  Google Scholar 

  14. Bhatla N, Dar L, Patro AR, et al. Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol. 2006; 25:398-402.

    Article  Google Scholar 

  15. Kerkar SC, Latta S, Salvi V, et al. Human papillomavirus infection in asymptomatic population. Sex Reprod Health. 2011; 2:7–11.

    Article  Google Scholar 

  16. Sowjanya AP, Jain M, Poli UR, et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis. 2005; 5:116.

    Article  Google Scholar 

  17. Franceschi S, Rajkumar T, Vaccarella S, et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case-control study. Int J Cancer. 2003; 107:127–33.

    Article  CAS  PubMed  Google Scholar 

  18. Kim SJ. Role of colposcopy and cervicography in screening and management of precancerous lesions and early invasive cancer of uterine cervix. J Obstet Gynecol. India 2000;50:134–46.

    Google Scholar 

  19. Peedicayil A, Abraham P, Sathish N, et al. Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer 2006;16:16(4):1591–5.

    Google Scholar 

  20. Duttagupta C, Sengupta S, Roy M, et al. Are Muslim women less susceptible to oncogenic human papillomavirus infection.A study from rural eastern India. Int J Gynecol Cancer. 2004;14:293–303.

    Article  CAS  PubMed  Google Scholar 

  21. Aggarwal R, Gupta S, Nijhawan R, et al. Prevalence of high-risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India. Indian J. Cancer. 2006;43:110–16.

    Article  CAS  PubMed  Google Scholar 

  22. Verteramo R, Pierangeli A, Calzolari E, et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect. 2006;8: 2517–21.

    Article  CAS  Google Scholar 

  23. Datta P, Bhatla N, Dar L, et al. Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol. 2010;34:157–61.

    Article  PubMed  Google Scholar 

  24. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001; 91:412–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parminder Kaur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaur, P., Aggarwal, A., Nagpal, M. et al. Prevalence and Clinical Utility of Human Papilloma Virus Genotyping in Patients with Cervical Lesions. J Obstet Gynecol India 64, 279–283 (2014). https://doi.org/10.1007/s13224-014-0508-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-014-0508-5

Keywords

Navigation